• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于病理参数的评分系统,用于预测局部晚期直肠癌术前放化疗后区域淋巴结转移:对局部切除的意义

A scoring system basing pathological parameters to predict regional lymph node metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer: implication for local excision.

作者信息

Wang Xiao-Jie, Chi Pan, Lin Hui-Ming, Lu Xing-Rong, Huang Ying, Xu Zong-Bin, Huang Sheng-Hui, Sun Yan-Wu, Ye Dao-Xiong, Yu Qian

机构信息

Department of Colorectal Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian 350001, People's Republic of China.

Department of Pathology, Union Hospital, Fujian Medical University, Fuzhou, Fujian 350001, People's Republic of China.

出版信息

Oncotarget. 2016 Nov 29;7(48):78487-78498. doi: 10.18632/oncotarget.10965.

DOI:10.18632/oncotarget.10965
PMID:27489356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5346655/
Abstract

Local excision is an alternative to radical surgery that is indicated in patients with locally advanced rectal cancer (LARC) who have a good response to chemoradiotherapy (CRT). Regional lymph node status is a major uncertainty during local excision of LARC following CRT. We retrospectively reviewed clinicopathologic variables for 244 patients with LARC who were treated at our institute between December 2000 and December 2013 in order to identify independent predictors of regional lymph node metastasis. Multivariate analysis of the training sample demonstrated that histopathologic type, tumor size, and the presence of lymphovascular invasion were significant predictors of regional nodal metastasis. These variables were then incorporated into a scoring system in which the total scores were calculated based on the points assigned for each parameter. The area under the curve in the receiver operating characteristic analysis was 0.750, and the cutoff value for the total score to predict regional nodal metastasis was 7.5. The sensitivity of our system was 73.2% and the specificity was 69.4%. The sensitivity was 77.8% and the specificity was 51.2% when the scoring system was applied to the testing sample. Using this system, we could accurately predict regional nodal metastases in LARC patients following CRT, which may be useful for stratifying patients in clinical trials and selecting potential candidates for organ-sparing surgery following CRT for LARC.

摘要

局部切除是根治性手术的一种替代方法,适用于对放化疗(CRT)反应良好的局部晚期直肠癌(LARC)患者。区域淋巴结状态是CRT后LARC局部切除过程中的一个主要不确定因素。我们回顾性分析了2000年12月至2013年12月期间在我院接受治疗的244例LARC患者的临床病理变量,以确定区域淋巴结转移的独立预测因素。对训练样本的多因素分析表明,组织病理学类型、肿瘤大小和淋巴管侵犯的存在是区域淋巴结转移的重要预测因素。然后将这些变量纳入一个评分系统,其中总分数是根据为每个参数分配的分数计算得出的。受试者工作特征分析中的曲线下面积为0.750,预测区域淋巴结转移的总分临界值为7.5。我们系统的敏感性为73.2%,特异性为69.4%。当将评分系统应用于测试样本时,敏感性为77.8%,特异性为51.2%。使用该系统,我们可以准确预测CRT后LARC患者的区域淋巴结转移,这可能有助于在临床试验中对患者进行分层,并为CRT后LARC的保留器官手术选择潜在候选者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/26a6d7357c41/oncotarget-07-78487-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/09258705ae66/oncotarget-07-78487-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/8f24a98e3291/oncotarget-07-78487-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/321460d477a0/oncotarget-07-78487-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/a5fdd22e83c1/oncotarget-07-78487-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/d1f6e41bfdcc/oncotarget-07-78487-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/48dedb6494e0/oncotarget-07-78487-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/3a6f78773a62/oncotarget-07-78487-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/26a6d7357c41/oncotarget-07-78487-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/09258705ae66/oncotarget-07-78487-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/8f24a98e3291/oncotarget-07-78487-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/321460d477a0/oncotarget-07-78487-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/a5fdd22e83c1/oncotarget-07-78487-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/d1f6e41bfdcc/oncotarget-07-78487-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/48dedb6494e0/oncotarget-07-78487-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/3a6f78773a62/oncotarget-07-78487-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0d/5346655/26a6d7357c41/oncotarget-07-78487-g008.jpg

相似文献

1
A scoring system basing pathological parameters to predict regional lymph node metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer: implication for local excision.一种基于病理参数的评分系统,用于预测局部晚期直肠癌术前放化疗后区域淋巴结转移:对局部切除的意义
Oncotarget. 2016 Nov 29;7(48):78487-78498. doi: 10.18632/oncotarget.10965.
2
Selecting stage ypT0-1N0 for locally advanced rectal cancer following preoperative chemoradiotherapy: implications for potential candidates of organ-sparing management.术前放化疗后局部进展期直肠癌选择ypT0-1N0期:对保留器官治疗潜在候选者的意义
Colorectal Dis. 2016 Oct;18(10):989-996. doi: 10.1111/codi.13297.
3
A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.用于预测局部晚期直肠癌新辅助放化疗后淋巴结阳性的列线图
Dis Colon Rectum. 2016 Aug;59(8):710-7. doi: 10.1097/DCR.0000000000000638.
4
Prediction of N0 Irradiated Rectal Cancer Comparing MRI Before and After Preoperative Chemoradiotherapy.术前放化疗前后MRI对N0期直肠癌的预测比较
Dis Colon Rectum. 2017 Nov;60(11):1184-1191. doi: 10.1097/DCR.0000000000000894.
5
Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy.对于接受术前放化疗的直肠癌患者,转移淋巴结比例更为重要。
World J Gastroenterol. 2015 Mar 21;21(11):3274-81. doi: 10.3748/wjg.v21.i11.3274.
6
Tumor compactness improves the preoperative volumetry-based prediction of the pathological complete response of rectal cancer after preoperative concurrent chemoradiotherapy.肿瘤致密性改善了术前同步放化疗后直肠癌病理完全缓解的基于术前容积的预测。
Oncotarget. 2017 Jan 31;8(5):7921-7934. doi: 10.18632/oncotarget.13855.
7
The impact of lymph node size to predict nodal metastasis in patients with rectal cancer after preoperative chemoradiotherapy.术前放化疗后直肠癌患者中淋巴结大小对预测淋巴结转移的影响。
Int J Colorectal Dis. 2015 Apr;30(4):459-64. doi: 10.1007/s00384-014-2099-0. Epub 2015 Jan 15.
8
Preoperative chemoradiotherapy changes the size criterion for predicting lateral lymph node metastasis in lower rectal cancer.术前放化疗改变了低位直肠癌侧方淋巴结转移预测的大小标准。
Int J Colorectal Dis. 2017 Nov;32(11):1631-1637. doi: 10.1007/s00384-017-2873-x. Epub 2017 Jul 31.
9
Nodal staging with MRI after neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: a fast and reliable method.局部进展期直肠癌新辅助放化疗后 MRI 下淋巴结分期:一种快速可靠的方法。
Eur Radiol. 2024 May;34(5):3205-3214. doi: 10.1007/s00330-023-10265-3. Epub 2023 Nov 6.
10
MRI-based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy.基于 MRI 的参数和临床危险因素预测新辅助放化疗后 ypT0 期直肠癌患者的淋巴结转移。
ANZ J Surg. 2024 Jun;94(6):1127-1132. doi: 10.1111/ans.18876. Epub 2024 Jan 22.

引用本文的文献

1
Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy.新辅助放化疗后局部晚期直肠癌患者中FOXK家族表达的预后价值
Onco Targets Ther. 2020 Sep 16;13:9185-9201. doi: 10.2147/OTT.S255956. eCollection 2020.

本文引用的文献

1
Clinical predictive factors of pathologic complete response in locally advanced rectal cancer.局部晚期直肠癌病理完全缓解的临床预测因素
Oncotarget. 2016 May 31;7(22):33374-80. doi: 10.18632/oncotarget.8133.
2
Use of Preoperative MRI to Select Candidates for Local Excision of MRI-Staged T1 and T2 Rectal Cancer: Can MRI Select Patients With N0 Tumors?使用术前磁共振成像(MRI)来选择MRI分期为T1和T2期直肠癌局部切除的候选者:MRI能否筛选出无淋巴结转移(N0)的患者?
Dis Colon Rectum. 2015 Oct;58(10):923-30. doi: 10.1097/DCR.0000000000000437.
3
Extramural depth of rectal cancer tumor invasion at thin-section MRI: predicting treatment response to neoadjuvant chemoradiation.
直肠癌肿瘤在薄层MRI上的壁外浸润深度:预测新辅助放化疗的治疗反应
Oncotarget. 2015 Oct 6;6(30):30277-86. doi: 10.18632/oncotarget.4623.
4
Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation.术前放化疗后局部进展期直肠癌选择局部切除的意义。
Oncotarget. 2015 May 10;6(13):11714-22. doi: 10.18632/oncotarget.3418.
5
Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation?直肠黏液腺癌:新辅助放化疗的不良候选者?
J Gastrointest Oncol. 2014 Aug;5(4):276-9. doi: 10.3978/j.issn.2078-6891.2014.020.
6
Restaging of locally advanced rectal cancer with magnetic resonance imaging and endoluminal ultrasound after preoperative chemoradiotherapy: a systemic review and meta-analysis.术前放化疗后磁共振成像和腔内超声局部进展期直肠癌再分期:系统评价和荟萃分析。
Dis Colon Rectum. 2014 Mar;57(3):388-95. doi: 10.1097/DCR.0000000000000022.
7
Practice parameters for the management of rectal cancer (revised).直肠癌管理的实践参数(修订版)
Dis Colon Rectum. 2013 May;56(5):535-50. doi: 10.1097/DCR.0b013e31828cb66c.
8
Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.新辅助放化疗后 ypT0-2 期直肠癌患者的淋巴结转移比较分析。
Dis Colon Rectum. 2013 Feb;56(2):135-41. doi: 10.1097/DCR.0b013e318278ff8a.
9
Predicting lymph node metastases in early rectal cancer.预测早期直肠癌的淋巴结转移。
Eur J Cancer. 2013 Mar;49(5):1104-8. doi: 10.1016/j.ejca.2012.10.005. Epub 2012 Oct 31.
10
Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy.新辅助治疗后 T2 期直肠癌腔内局部切除术与腹腔镜全直肠系膜切除术的随机临床试验。
Br J Surg. 2012 Sep;99(9):1211-8. doi: 10.1002/bjs.8821.